College of Pharmacy, Chungnam National University, Daejeon, Korea.
Planta Med. 2010 Jan;76(1):79-81. doi: 10.1055/s-0029-1185944. Epub 2009 Jul 27.
Glucose uptake assay-guided fractionations on the methanol extract of Sophorae Flos led to the isolation of the flavonoids rutin (1), narcissin (2), quercetin (3), tamarixetin (4), and kaempferol (5) and the isoflavonoids cajanin (6), genistein (7), orobol (8), and pratensein (9). Among them, 1, 4, 5, 6, 8, and 9 significantly improved basal glucose uptake in HepG2 cells. Their improving effects were concentration dependent. Compounds 4, 5, 6, and 9 exhibited effects stronger than that of rosiglitazone, which has been used as an antidiabetic drug. However, 2, 3, and 7 did not show any improving effects. Stimulating glucose uptake into peripheral cells may be responsible for reducing the level of blood glucose in the circulation. Therefore, these findings demonstrate a potential to develop these flavonoids and isoflavonoids as hypoglycemic drugs.
葡萄糖摄取测定法指导槐米花甲醇提取物的分段分离得到了黄酮类化合物芦丁(1)、水仙苷(2)、槲皮素(3)、柽柳素(4)和山奈酚(5)以及异黄酮类化合物鸡纳皮定(6)、染料木黄酮(7)、奥洛波醇(8)和荭草苷(9)。其中,1、4、5、6、8 和 9 可显著提高 HepG2 细胞的基础葡萄糖摄取。它们的促进作用呈浓度依赖性。化合物 4、5、6 和 9 的作用强于已用作抗糖尿病药物的罗格列酮。然而,2、3 和 7 没有表现出任何改善作用。刺激外周细胞摄取葡萄糖可能有助于降低循环血液中的血糖水平。因此,这些发现表明这些类黄酮和异黄酮具有开发为降血糖药物的潜力。